Loading profile...
Boyd Williams
Bryan is an internationally recognised cancer researcher and research administrator, with significant business experience. He has held a number of governance roles, including with a NASDAQ listed biotech company. Presently, he serves on the boards of two Australian and one American privately held biotechnology companies. He is also a co-founder of an American biotechnology company. Bryan was Director and CEO of the Hudson Institute of Medical Research. He is currently Emeritus Director and Distinguished Scientist at the Hudson Institute in Melbourne. He has a BSc (Hons) and PhD in Microbiology from the University of Otago.
Education
BSc (Hons), PhD
About this profile
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
Source registers used on this page
- NZX market announcements and continuous-disclosure filings
- Audited annual reports lodged with NZX
- FMA Disclose Register (substantial product holders, insider trades)
- NZ Companies Office records (Companies Act 1993 §215)
- NZ Government Gazette appointment notices
- Issuer earnings webcasts and investor presentations
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.
University of Otago